BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behrens T, Bonberg N, Casjens S, Pesch B, Brüning T. A practical guide to epidemiological practice and standards in the identification and validation of diagnostic markers using a bladder cancer example. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2014;1844:145-55. [DOI: 10.1016/j.bbapap.2013.07.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Mordente A, Meucci E, Martorana GE, Silvestrini A. Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives. In: Scatena R, editor. Advances in Cancer Biomarkers. Dordrecht: Springer Netherlands; 2015. pp. 9-26. [DOI: 10.1007/978-94-017-7215-0_2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
2 Frantzi M, Bhat A, Latosinska A. Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development. Clin Transl Med 2014;3:7. [PMID: 24679154 DOI: 10.1186/2001-1326-3-7] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 10.6] [Reference Citation Analysis]
3 May C, Nordhoff E, Casjens S, Turewicz M, Eisenacher M, Gold R, Brüning T, Pesch B, Stephan C, Woitalla D, Penke B, Janáky T, Virók D, Siklós L, Engelhardt JI, Meyer HE. Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array. PLoS One 2014;9:e89596. [PMID: 24586901 DOI: 10.1371/journal.pone.0089596] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
4 Virk RK, Abro S, de Ubago JMM, Pambuccian SE, Quek ML, Wojcik EM, Mehrotra S, Chatt GU, Barkan GA. The value of the UroVysion® FISH assay in the risk-stratification of patients with “atypical urothelial cells” in urinary cytology specimens: The Value of the UroVysion® FISH Assay. Diagn Cytopathol 2017;45:481-500. [DOI: 10.1002/dc.23686] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
5 De Clercq N, Bussche JV, Van Meulebroek L, Croubels S, Delahaut P, Buyst D, Martins J, Stahl-zeng J, Vanhaecke L. Metabolic fingerprinting reveals a novel candidate biomarker for prednisolone treatment in cattle. Metabolomics 2016;12. [DOI: 10.1007/s11306-015-0887-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 14] [Article Influence: 7.1] [Reference Citation Analysis]
6 Miremami J, Kyprianou N. The promise of novel molecular markers in bladder cancer. Int J Mol Sci 2014;15:23897-908. [PMID: 25535079 DOI: 10.3390/ijms151223897] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
7 Aguilar-Madrid G, Pesch B, Calderón-Aranda ES, Burek K, Jiménez-Ramírez C, Juárez-Pérez CA, Ochoa-Vázquez MD, Torre-Bouscoulet L, Acosta-Saavedra LC, Sada-Ovalle I, García-Figueroa J, Alvarado-Cabrero I, Castillo-González P, Báez-Saldaña AR, Pérez-Padilla JR, Osnaya-Juárez J, Rivera-Rosales RM, García-Bazán EM, Bautista-Aragón YL, Lazcano-Hernandez E, Munguía-Canales DA, Argote-Greene LM, Taeger D, Weber DG, Casjens S, Raiko I, Brüning T, Johnen G. Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population. Int J Med Sci 2018;15:883-91. [PMID: 30008600 DOI: 10.7150/ijms.23939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Mikalsen S. Proteomics made more accessible. Proteomics 2014;14:989-90. [DOI: 10.1002/pmic.201400064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Sekula P, Mallett S, Altman DG, Sauerbrei W. Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles. PLoS One 2017;12:e0178531. [PMID: 28614415 DOI: 10.1371/journal.pone.0178531] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
10 Khadjavi A, Mannu F, Destefanis P, Sacerdote C, Battaglia A, Allasia M, Fontana D, Frea B, Polidoro S, Fiorito G, Matullo G, Pantaleo A, Notarpietro A, Prato M, Castagno F, Vineis P, Gontero P, Giribaldi G, Turrini F. Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins. Br J Cancer 2015;113:469-75. [PMID: 26125446 DOI: 10.1038/bjc.2015.232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
11 Chen H, Knebel P, Brenner H. Empirical evaluation demonstrated importance of validating biomarkers for early detection of cancer in screening settings to limit the number of false-positive findings. J Clin Epidemiol. 2016;75:108-114. [PMID: 26836253 DOI: 10.1016/j.jclinepi.2016.01.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Pesch B, Taeger D, Johnen G, Gawrych K, Bonberg N, Schwentner C, Wellhäußer H, Kluckert M, Leng G, Nasterlack M. Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines. Int Arch Occup Environ Health. 2014;87:715-724. [PMID: 24129706 DOI: 10.1007/s00420-013-0916-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]